Flumazenil
|
|
Flumazenil Eigenschaften
- Schmelzpunkt:
- 201-203°C
- Siedepunkt:
- 528.0±50.0 °C(Predicted)
- Dichte
- 1.39±0.1 g/cm3(Predicted)
- storage temp.
- Sealed in dry,2-8°C
- L?slichkeit
- Soluble in DMSO to 25mM
- pka
- 0.86±0.20(Predicted)
- Aggregatzustand
- solid
- Farbe
- white
- Wasserl?slichkeit
- 128 mg/L
- Merck
- 14,4135
- Stabilit?t:
- Stable for 2 years from date of purchase as supplied. Solutions in DMSO may be stored at -20°C for up to 3 months.
- Major Application
- pharmaceutical (small molecule)
- InChI
- InChI=1S/C15H14FN3O3/c1-3-22-15(21)13-12-7-18(2)14(20)10-6-9(16)4-5-11(10)19(12)8-17-13/h4-6,8H,3,7H2,1-2H3
- InChIKey
- OFBIFZUFASYYRE-UHFFFAOYSA-N
- SMILES
- N12C=NC(C(OCC)=O)=C1CN(C)C(=O)C1=CC(F)=CC=C12
- CAS Datenbank
- 78755-81-4(CAS DataBase Reference)
- NIST chemische Informationen
- Flumazenil(78755-81-4)
Sicherheit
- Risiko- und Sicherheitserkl?rung
- Gefahreninformationscode (GHS)
| Kennzeichnung gef?hrlicher | Xi | ||
|---|---|---|---|
| R-S?tze: | 36/37/38 | ||
| S-S?tze: | 26-27-36/37/39 | ||
| WGK Germany | 2 | ||
| RTECS-Nr. | NI2922170 | ||
| HS Code | 2933997500 | ||
| Speicherklasse | 11 - Combustible Solids | ||
| Toxizit?t | LD50 in mice, rats (mg/kg): 4000, 1360 i.p.; 4300, 6000 orally (Hunkeler) |
| Bildanzeige (GHS) |
|
||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alarmwort | Warnung | ||||||||||||||
| Gefahrenhinweise |
|
||||||||||||||
| Sicherheit |
|
Flumazenil Chemische Eigenschaften,Einsatz,Produktion Methoden
R-S?tze Betriebsanweisung:
R36/37/38:Reizt die Augen, die Atmungsorgane und die Haut.S-S?tze Betriebsanweisung:
S26:Bei Berührung mit den Augen sofort gründlich mit Wasser abspülen und Arzt konsultieren.S27:Beschmutzte, getr?nkte Kleidung sofort ausziehen.
S36/37/39:Bei der Arbeit geeignete Schutzkleidung,Schutzhandschuhe und Schutzbrille/Gesichtsschutz tragen.
Beschreibung
Flumazenil is a benzodiazepine antagonist useful as a fast-acting antidote in the treatment of benzodiazepine intoxication, and in reversing the central sedative effects of benzodiazepines during anesthesia.Chemische Eigenschaften
Flumazenil is a white to off-white crystalline compound with an octanol:buffer partition coefficient of 14 to 1 at pH 7.4. It is insoluble in water but slightly soluble in acidic aqueous solutions.Verwenden
Flumazenil is an imidazodiazepine which selectively blocks the central effects of classic benzodiazepines. It is used as benzodiazepine antagonist sedation reversal drug.Definition
ChEBI: Flumazenil is an organic heterotricyclic compound that is 5,6-dihydro-4H-imidazo[1,5-a][1,4]benzodiazepine which is substituted at positions 3, 5, 6, and 8 by ethoxycarbonyl, methyl, oxo, and fluoro groups, respectively. It is used as an antidote to benzodiazepine overdose. It has a role as a GABA antagonist and an antidote to benzodiazepine poisoning. It is an ethyl ester, an organofluorine compound and an imidazobenzodiazepine.synthetische
The Synthesis of Flumazenil
Starting with 4-fluoroaniline (15) the isatin 17 is synthesized via the Sandmeyer synthesis; isatin is then oxidized with peracetic acid to the isatoic anhydride 18. Reaction with sarcosine in DMF leads to the benzodiazepine-2,5-dione 19. This is converted to the iminochloride by reaction with POCI3 . In the key step the imidazoester is built up by reaction with deprotonated ethyl isocyanoacetate [8]. Since ethyl isocyanoacetate is not very stable, an alternative synthesis based on the synthesis of midazolam was developed for large scale-production. Tnthis synthesis diethylmalonate is used. The diester 21 is then transformed to the monoester 22 hy deethoxycarbonylation. Nitrosation and catalytic reduction lead to the amino compound 23. The final carbon atom is introduced by reaction with the orthoester.
Biologische Aktivit?t
Flumazenil is a GABAA receptor antagonist with non-selective for α 1, α 2, α 3 or α 5 (IC50 = 2 nM in a radioligand binding assay using rat cortical synaptosomes). Flumazenil also acts as a partial agonist of GABAA receptors, decreasing the amplitude of electrically stimulated population spikes in rat hippocampal CA1 pyramidal neurons. It increases the number of entries into the open arms of the elevated plus maze in high-anxiety BALB/c, but not C57BL/6, mice when administered at doses ranging from 0.1 to 1,000 μg/kg. Flumazenil (5 and 10 mg/kg) prevents a reduction in burying behavior induced by the GABAA receptor positive allosteric modulator allopregnanolone in ovariectomized rats when administered at doses of 5 and 10 mg/kg. Formulations containing flumazenil have been used to reverse sedation induced by benzodiazepines and in the treatment of benzodiazepine overdose or withdrawal.Pharmakokinetik
Flumazenil is a competitive antagonist at the GA BAA benzodiazepine binding site for all other ligands. I t rapidly reverses the CN S and dangerous physiological effects of benzodiazepines following iatrogenic overdose or deliberate self-harm. I t has no effect on benzodiazepine metabolism. Flumazenil is rapidly cleared from plasma and metabolised by the liver and has a very short elimination half-life (<1h). Its duration of action depends on the dose administered and the duration of action of the drug to be antagonised; repeated administration or infusions may be necessary.Mode of action
Flumazenil, an imidazobenzodiazepine derivative, antagonizes the actions of benzodiazepines on the central nervous system. Flumazenil competitively inhibits the activity at the benzodiazepine recognition site on the GABA/benzodiazepine receptor complex. In animal experiments the effects of compounds showing no affinity for the benzodiazepine receptor, e.g. barbiturates, ethanol, meprobamate, GABA mimetics, adenosine receptor agonists and other agents were not affected by flumazenil, but those of nonbenzodiazepine agonists of benzodiazepine receptors, such as cyclopyrrolones (e.g. zopiclone) and triazolopyridazines were blocked.Einzelnachweise
[1] HOWARD AN J G. Flumazenil in benzodiazepine overdose[J]. Canadian Medical Association journal, 2016, 6 1: E537-E537. DOI:10.1503/cmaj.160357[2] ALEXANDER T GALLO Gary H. Pharmacological uses of flumazenil in benzodiazepine use disorders: a systematic review of limited data.[J]. Journal of Psychopharmacology, 2021, 35 3: 211-220. DOI:10.1177/0269881120981390
Flumazenil Upstream-Materialien And Downstream Produkte
Upstream-Materialien
6-Fluoroisatoic anhydride
Wasserstoffperoxid
5-Fluoroisatin
N,N-Dimethyl-anilin
Natrium-2-methylpropan-2-olat
Anthranilic acid
Sarkosin
Ethylcyanacetat
Kaliumacetat
Downstream Produkte
Flumazenil Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 438)Lieferanten
| Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
|---|---|---|---|---|---|
| Jinan Million Pharmaceutical Co., Ltd | 0531-68659554 +8613031714605 |
info@millionpharm.com | China | 183 | 58 |
| Hebei Yanxi Chemical Co., Ltd. | +86-17531190177 |
faithe@yan-xi.com | China | 5838 | 58 |
| RongNa Biotechnology Co.,Ltd | +86-86-13583358881 +8618560316533 |
Brad@rongnabiotech.com | China | 3371 | 58 |
| LY Global chemicals co.,ltd . | +86-1837154342 |
info@lychems.cn | China | 968 | 58 |
| Xiamen Wonderful Bio Technology Co., Ltd. | +86-13043004613 |
Sara@xmwonderfulbio.com | China | 265 | 58 |
| Nantong Guangyuan Chemicl Co,Ltd | +86-17331189928 |
admin@guyunchem.com | China | 611 | 58 |
| Hangzhou Hyper Chemicals Limited | +86-0086-57187702781 +86-13675893055 |
info@hyper-chem.com | China | 309 | 58 |
| Moxin Chemicals | +86-17320513646 +86-17320513646 |
anna@molcoo.com | China | 9998 | 58 |
| Wuhan JiyunZen Tech Co., Ltd. | +86-18062099985 |
Amyjiyunzen@yeah.net | China | 672 | 58 |
| Henan Tianfu Chemical Co.,Ltd. | +86-0371-55170693 +86-19937530512 |
info@tianfuchem.com | China | 21531 | 55 |
78755-81-4()Verwandte Suche:
Acetonitril
1,1-Diethoxytrimethylamin
Methylacrylat
Kresoxim-methyl
Urethan
Methyl-4-hydroxybenzoat
Paraquat-dichlorid
Triethylorthoformiat
Basic Violet 1
2,6-Dimethyloct-7-en-2-ol
Methanol
Ameisens?ure-ethylester
1-Methylimidazol
Methyl
Ethyl-chlorformiat
fluoro jade
- FluMenazil
- Ro 15-1788/000
- Ro 1722
- Ro 41-8157
- FluMazenil API
- FluMazenil(Ro 15-1788)
- ethyl 12-fluoro-8-Methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(14),3,5,10,12-pentaene-5-carboxylate
- Ethyl 8-fluoro-5-methyl-5,6-dihydro-6-oxo-4H-imidazo(1,5-a)(1,4)benzodiazepine-3-carboxylate
- 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazol[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
- YM-684
- ANEXATE
- Flumazepil
- Flumazenil (200 mg)
- Flumazenil、Flumazepil
- FlumazenilUsDmf
- Ethyl 8-fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-α][1,4]benzodiazepine-3-carboxylate
- Lanexat
- Mazicon
- Rcr-15-1788
- ethyl 8-fluoro-5-methyl-6-oxo-5,6-dihydro-4h-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- FLUMAZENIL
- FluMazenil USP
- 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-4H-IMIDAZO[1,5-A][1,4]BENZO-DIAZEPINE-3-CARBOXYLIC ACID ETHYL ESTER
- 8-FLUORO-5,6-DIHYDRO-5-METHYL-6-OXO-4H-IMIDAZO[1,5-A][1,4]BENZODIAZEPINE-3-CARBOXYLIC ACID ETHYL EST
- RO 15-1788
- FLUMAZENIL;RO 15-1788; RO15-1788;
- 1-4-Amino-3-chloro-5-(trifluoromethyl)phenyl eth Flumazenil
- Flumazenil, 99.5%
- ethyl 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylate
- Flumazenil78755-81-4
- 8-Fluoro-5,6-dihydro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, ethyl ester
- 8-fluoro-5-methyl-6-oxo-4H-imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid ethyl ester
- Flumazenil Flumazenil
- Flumazenil >
- Flumazenil USP/EP/BP
- Flumazenil (1273808)
- 3R)-(+)-Tartaric acid
- ethyl 8-fluoro-5-Methyl-6-oxo-5,6-dihydro-4H-benzo[f]iMidazo[1,5-a][1,4]diazepine-3-carboxylate
- Romazicon
- Fluorine Masini
- 4H-Imidazo[1,5-a][1,4]benzodiazepine-3-carboxylic acid, 8-fluoro-5,6-dihydro-5-methyl-6-oxo-, ethyl ester
- Flumazenil in methanol
- Flumazenil, Benzodiazepine antagonist
- Flumazenil, Benzodiazepine antagonist (DMSO solution)
- Flumazenil, 10 mM in DMSO
- Flumazenil - Bio-X ?
- Flumazenib
- Flumazenil, 1mg/ml in Ethanol
- ethyl 12-fluoro-8-methyl-9-oxo-2,4,8-triazatricyclo[8.4.0.0^{2,6}]tetradeca-1(10),3,5,11,13-pentaene-5-carboxylate
- FMZ
- 78755-81-4
- 78755-8104
- 78775-81-4
- C15H14FN3O3
- Other APIs
- ZEBETA
- API
- antagonist




